Cargando…

Evaluation of Adjuvant Chemotherapy-Associated Steatosis (CAS) in Colorectal Cancer

Chemotherapy-associated steatosis is poorly understood in the context of colorectal cancer. In this study, Stage II–III colorectal cancer patients were retrospectively selected to evaluate the frequency of chemotherapy-associated steatosis and to determine whether patients on statins throughout adju...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Michelle C. M., Kachura, Jacob J., Vlachou, Paraskevi A., Dzulynsky, Raissa, Di Tomaso, Amy, Samawi, Haider, Baxter, Nancy, Brezden-Masley, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395441/ https://www.ncbi.nlm.nih.gov/pubmed/34436031 http://dx.doi.org/10.3390/curroncol28040265

Ejemplares similares

The Association of Oxaliplatin-Containing Adjuvant Chemotherapy Duration with Overall and Cancer-Specific Mortality in Individuals with Stage III Colon Cancer: A Population-Based Retrospective Cohort Study
por: Sue-Chue-Lam, Colin, et al.
Publicado: (2023)

Gynecologic Symptoms among Hormone Receptor-Positive Breast Cancer Patients on Oral Endocrine Therapy: A Cross-Sectional Study
por: Moskalewicz, Alexandra, et al.
Publicado: (2022)

Clinicians’ Perspectives on Barriers to Discussing Infertility and Fertility Preservation With Young Women With Cancer
por: Covelli, Andrea, et al.
Publicado: (2019)

Iron Surveillance and Management in Gastro-Intestinal Oncology Patients: A National Physician Survey †
por: Richard, Emilie S., et al.
Publicado: (2023)

Randomised controlled trials of non-pharmacological interventions to improve patient-reported outcomes of colonoscopy: a scoping review
por: Sue-Chue-Lam, Colin, et al.
Publicado: (2023)

Redefining Heart Failure in Breast Cancer
por: Volgman, Annabelle Santos, et al.
Publicado: (2022)

Cancer and Cardiovascular Disease: The Complex Labyrinth
por: Dent, Susan, et al.
Publicado: (2015)

Lgr5 and stem/progenitor gene expression in gastric/gastroesophageal junction carcinoma – significance of potentially retained stemness
por: Yoon, Ju-Yoon, et al.
Publicado: (2020)

Autophagic Heterogeneity in Gastric Adenocarcinoma
por: Yoon, Ju-Yoon, et al.
Publicado: (2021)

Adjuvant chemotherapy for colorectal cancer
por: Maughan, T S
Publicado: (2001)

Intestinal Metaplasia and the Risk of Gastric Cancer in an Immigrant Asian Population
por: Abadir, Amir, et al.
Publicado: (2012)

Histo- and immunohistochemistry-based estimation of the TCGA and ACRG molecular subtypes for gastric carcinoma and their prognostic significance: A single-institution study
por: Yoon, Ju-Yoon, et al.
Publicado: (2019)

Timing of Adjuvant Chemotherapy in Colorectal Cancer Patients
por: Baek, Moo-Jun
Publicado: (2013)

Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
por: Glimelius, Bengt, et al.
Publicado: (2020)

Neurocognitive outcomes following fetal exposure to chemotherapy for gestational breast cancer: A Canadian multi-center cohort study
por: Maxwell, Cynthia, et al.
Publicado: (2021)

THE ASSOCIATION BETWEEN PREOPERATIVE CHEMOTHERAPY AND THE PREVALENCE OF HEPATIC STEATOSIS IN HEPATECTOMY FOR METASTATIC COLORECTAL CANCER
por: KALIL, Antonio Nocchi, et al.
Publicado: (2014)

Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian Perspective
por: Ferrario, Cristiano, et al.
Publicado: (2022)

Precision medicine for adjuvant chemotherapy of resected colorectal cancer
por: Miyamoto, Yuji, et al.
Publicado: (2020)

Positive progress: current and evolving role of immune checkpoint inhibitors in metastatic triple-negative breast cancer
por: Simmons, Christine E., et al.
Publicado: (2020)

Development of Hepatic Steatosis After Chemotherapy for Non‐Hodgkin Lymphoma
por: Ben‐Yakov, Gil, et al.
Publicado: (2018)

The Aetiology of Delay to Commencement of Adjuvant Chemotherapy following Colorectal Resection
por: Simpson, G. S., et al.
Publicado: (2014)

Cardiotoxic Profile and Arterial Stiffness of Adjuvant Chemotherapy for Colorectal Cancer
por: Visvikis, A, et al.
Publicado: (2020)

A population‐based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with triple‐negative breast cancer
por: Brezden‐Masley, Christine, et al.
Publicado: (2020)

Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study
por: O’Shaughnessy, Joyce, et al.
Publicado: (2020)

A population-based comparison of treatment, resource utilization, and costs by cancer stage for Ontario patients with HER2-positive breast cancer
por: Brezden-Masley, Christine, et al.
Publicado: (2020)

A population-based comparison of treatment patterns, resource utilization, and costs by cancer stage for Ontario patients with hormone receptor-positive/HER2-negative breast cancer
por: Brezden-Masley, Christine, et al.
Publicado: (2020)

The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer
por: Chu-Yuan, Hong, et al.
Publicado: (2013)

Targeting HER2-low in metastatic breast cancer: an evolving treatment paradigm
por: Yang, Charlie, et al.
Publicado: (2023)

Adjuvant chemotherapy
por: Glimelius, B.
Publicado: (2013)

The Role of Adjuvant Chemotherapy for Colorectal Liver Metastasectomy after Pre-Operative Chemotherapy: Is the Treatment Worthwhile?
por: Wang, Yun, et al.
Publicado: (2017)

Helicobacter pylori and gastrointestinal symptoms in diagnostics and adjuvant chemotherapy of colorectal cancer
por: SOVERI, LEENA-MAIJA, et al.
Publicado: (2014)

Modified Folfox6 as Adjuvant Chemotherapy in Vietnamese Patients With Colorectal Cancer
por: Nguyen, T. Quang, et al.
Publicado: (2019)

Effect of adjuvant chemotherapy after pulmonary metastasectomy on the prognosis of colorectal cancer
por: Shiomi, Kazu, et al.
Publicado: (2017)

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
por: Kotani, Daisuke, et al.
Publicado: (2023)

Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial
por: Krzyzanowska, Monika K, et al.
Publicado: (2021)

An international survey of healthcare providers’ knowledge of cardiac complications of cancer treatments
por: Peng, J., et al.
Publicado: (2019)

Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis
por: Wilson, Florence R., et al.
Publicado: (2017)

Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain
por: Rayson, Daniel, et al.
Publicado: (2022)

Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on “Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29, 9891–9895”
por: Rayson, Daniel, et al.
Publicado: (2023)

Managing the Risk of Lung Toxicity with Trastuzumab Deruxtecan (T-DXd): A Canadian Perspective
por: Henning, Jan-Willem, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j2dhgaq252tk2sc1dsbvg2qd3u